ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Lectroid
|
9.9K |
4.4M |
7 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Lectroid
|
155 |
67K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
155
|
67K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Alpha-synuclein induced synucleinopathies and NBIA's
|
|
Lectroid
|
10 |
3.0K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
10
|
3.0K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Lectroid
|
155 |
67K |
7 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
155
|
67K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Lectroid
|
155 |
67K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
155
|
67K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
8 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
19 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
19
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Chart
|
|
Lectroid
|
20 |
4.1K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
20
|
4.1K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Chart
|
|
Lectroid
|
20 |
4.1K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
20
|
4.1K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
10 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
2 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
5 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Iron chelation to treat obesity?
|
|
Lectroid
|
4 |
1.3K |
4 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
4
|
1.3K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
Lectroid
|
24 |
6.3K |
6 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
24
|
6.3K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
Lectroid
|
34 |
7.7K |
6 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
34
|
7.7K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Lectroid
|
2.0K |
702K |
13 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
2.0K
|
702K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
HYPED UP TO THE MAX
|
|
Lectroid
|
89 |
23K |
10 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
89
|
23K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
HYPED UP TO THE MAX
|
|
Lectroid
|
89 |
23K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
89
|
23K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
5.0K |
1.3M |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
5.0K
|
1.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
5.0K |
1.3M |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
5.0K
|
1.3M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
5.0K |
1.3M |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
5.0K
|
1.3M
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints John Han, PharmD, as VP Medical Affairs
|
|
Lectroid
|
9 |
2.3K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
2.3K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints John Han, PharmD, as VP Medical Affairs
|
|
Lectroid
|
9 |
2.3K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
2.3K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
297
|
94K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
5.0K |
1.3M |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
5.0K
|
1.3M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Lectroid
|
5.0K |
1.3M |
3 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
5.0K
|
1.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
8 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
0 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
9 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
297
|
94K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
12 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
297
|
94K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
29 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
94K
|
29
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
Lectroid
|
297 |
94K |
6 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
94K
|
6
|
|